Genetics Generation Advancement Corp. (TPEX:4160)
49.10
+0.45 (0.92%)
Jul 16, 2025, 1:30 PM CST
TPEX:4160 Revenue
Genetics Generation Advancement had revenue of 143.37M TWD in the quarter ending March 31, 2025, a decrease of -14.09%. This brings the company's revenue in the last twelve months to 638.35M, up 2.17% year-over-year. In the year 2024, Genetics Generation Advancement had annual revenue of 661.86M with 11.71% growth.
Revenue (ttm)
638.35M
Revenue Growth
+2.17%
P/S Ratio
2.05
Revenue / Employee
6.14M
Employees
104
Market Cap
1.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 661.86M | 69.36M | 11.71% |
Dec 31, 2023 | 592.50M | 44.69M | 8.16% |
Dec 31, 2022 | 547.81M | 28.30M | 5.45% |
Dec 31, 2021 | 519.51M | 76.38M | 17.24% |
Dec 31, 2020 | 443.13M | 13.75M | 3.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 40.47M |
PharmaEssentia | 11.34B |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 117.33M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Lumosa Therapeutics | 43.59M |